Chronic Pain

BRIDGEWATER, N.J. and CAESAREA, Israel — September 23, 2026 Theranica announced peer-reviewed results from a study evaluating its Your...

Burlington, Massachusetts, U.S., September 10, 2026 Consano Bio, Inc. has announced the publication of peer-reviewed nonclinical research evaluating C-1101,...

Munich, Germany, September 10, 2026 Ethris GmbH and the European Investment Bank (EIB) have signed a €30 million financing...

San Diego, California, and Suzhou, China, September 10, 2026 Adagene Inc. and Third Arc Bio, Inc. have announced the...

AARHUS, Denmark — September 10, 2026 Teitur Trophics announced successful results from the Phase I clinical trial of TT-P34,...

AUSTIN, Texas — September 10, 2026 EPIK Biosciences announced continued progress in developing proprietary synergistic combination medicines targeting mental...

Cambridge, Massachusetts, August 18, 2026 Brixton Biosciences has strengthened its Board of Directors with the appointment of three experienced...

BURLINGTON, Mass., August 18, 2026 Consano Bio, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted...

THE WOODLANDS, Texas, August 12, 2026 Autonomix Medical, Inc. announced the successful completion of a Good Laboratory Practice (GLP)...

RICHMOND, Va., July 20, 2026 Virginia’s Advanced Pharmaceutical Manufacturing (APM) Tech Hub has secured a $15.97 million investment from...